STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 18, 2024, for shares of Calliditas Therapeutics AB - CALT

Group 1 - Monteverde & Associates PC is investigating Calliditas Therapeutics AB in relation to a tender offer from Asahi Kasei Corporation, which proposes to acquire all outstanding shares of Calliditas stock for SEK 0.04 in cash per ADS [1] - The tender offer from Asahi Kasei Corporation is set to expire on July 18, 2024 [2] - Monteverde & Associates PC has a successful track record in recovering money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report [1][2] Group 2 - The firm is headquartered in the Empire State Building, New York City, and operates as a national class action securities firm [2] - Contact information for inquiries regarding the tender offer and shareholder concerns is provided, including an email and telephone number for Juan Monteverde, Esq. [3]